Where metastatic drugs are available in Canada
Palbociclib is also approved for use in combination with fulvestrant
Ontario drug programs: Exceptional Access Program
*Please Note: Ontario, Nova Scotia, New Brunswick, PEI and Newfoundland & Labrador have limited coverage for the cost of oral medications, forcing many patients to use private insurance or pay out of pocket. Check with your oncologist to see if you have coverage.